BiotechTube
Home/Tychon Bioscience/Charles Muscoplat, Ph.D.
CM

Charles Muscoplat, Ph.D.

Chief Commercialization Specialist

Tychon Bioscience

Therapeutic Areas

Oncology

Tychon Bioscience Pipeline

DrugIndicationPhase
TYC201 (Anti-EpCAM PARs)Solid Tumors (Breast/Colon)Pre-clinical
Anti-CD133 PARsCancer Stem CellsDiscovery
Anti-CD19 PARsLeukemia/LymphomaDiscovery
Universal CAR T-cell Hybrid CAR/PARNot SpecifiedDiscovery

Leadership Team at Tychon Bioscience

DJ
Danny J Cunagin
Chief Executive Officer
AZ
Arek Z. Dudek, MD, Ph.D.
Chief Clinical Specialist
CR
Carston Rick Wagner, Ph.D.
Chief Scientific Officer
JP
Jacob Petersburg, Ph.D.
Senior Scientist & Project Manager
View full Tychon Bioscience profile